Overview
- Description
The company develops an epigenetic blood test for early Alzheimer's detection using next-generation sequencing to aid diagnosis and accelerate drug discovery.
- Website
- Country
- Spain
- Sector
- Medical Technologies
ADmit Therapeutics S.L.
A Methylation Profiling Diagnostic for Early Diagnosis of Alzheimer’s disease